Summary
In a significant market movement during July 2023, thymia was the subject of a vc funding. The transaction achieved a gross valuation of £2,084,400. Leading the round was Syndicate Room’s Access EIS Fund, Nadav Rosenberg, Calm Storm Ventures, Entrepreneur First, Kodori Ventures, Amanda M Cardinale, Crowdcube, Form Ventures.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
Syndicate Room’s Access EIS Fund
Lead Investor / Acquirer
Nadav Rosenberg
Lead Investor / Acquirer
Calm Storm Ventures
Lead Investor / Acquirer
Entrepreneur First
Lead Investor / Acquirer
Kodori Ventures
Lead Investor / Acquirer
Amanda M Cardinale
Lead Investor / Acquirer
Crowdcube
Lead Investor / Acquirer
Form Ventures
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Seed prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in